Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Ramsay Sime Darby Forms $135 Million JV with Chengdu Hospital Operator

publication date: May 18, 2015
Ramsay Sime Darby Health Care (RSD), an Australia-Malaysia hospital operator, will pay $135 million to form a hospital Joint Venture with a Chengdu hospital operator. The JV will own a 5-hospital package of hospitals in Chengdu. Ramsay Health Care operates 214 hospitals in Australia. In 2013, it formed a partnership with Sime Darby Berhad, a Malaysian conglomerate, to operate three hospitals in Malaysia and three more in Indonesia. RSD said it would use the Chengdu JV as a basis to acquire additional hospitals in China. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here